GlassScriptPhysician profile
Richard Lichti
NPI 1912915778
$1,258.76
in general payments reported to CMS, 2019-2025
29 companies · $200 in 2025
The $200 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $174 · 2020: $272 · 2022: $149 · 2023: $308 · 2024: $156 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $664.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $664.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blueprint Medicines Corporation | $124.99 | 2023 | Ayvakit |
| Astrazeneca Pharmaceuticals LP | $121.87 | 2023 | Farxiga |
| Abbvie INC. | $114.78 | 2022-2025 | |
| Medtronic Vascular, INC. | $112.11 | 2020 | |
| Pfizer INC. | $94.20 | 2022-2025 | |
| Ibsa Pharma INC. | $85.62 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $56.02 | 2024 | Koselugo |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $54.92 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $53.31 | 2023-2025 | |
| Lilly USA, LLC | $35.60 | 2020-2022 | |
| Allergan, INC. | $35.58 | 2019-2020 | |
| Fidia Pharma USA INC. | $33.48 | 2025 | Hymovis |
| Amgen INC. | $28.57 | 2022-2024 | Repatha, Otezla |
| Corcept Therapeutics | $28.43 | 2025 | Korlym |
| Boston Scientific Corporation | $24.33 | 2019 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $22.74 | 2024 | |
| Glaxosmithkline, LLC. | $22.07 | 2023 | Shingrix, Arexvy |
| Noctrix Health, INC. | $22.06 | 2025 | Nidra |
| Depuy Synthes Sales INC. | $21.61 | 2024 | Orthovisc, Monovisc |
| Endo Pharmaceuticals INC. | $19.61 | 2019 | |
| Kaleo, INC. | $18.84 | 2020 | |
| Exact Sciences Corporation | $18.79 | 2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $17.80 | 2020 | |
| Orthogenrx INC. | $17.41 | 2019 | |
| Philips North America LLC | $17.25 | 2019 | |
| Genentech USA, INC. | $16.79 | 2019 | |
| Therapeuticsmd, INC. | $14.13 | 2019 | |
| Idorsia Pharmaceuticals US INC | $13.46 | 2023 | Quviviq |
| Hologic Sales and Service, LLC | $12.39 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Lichti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.